To screen ETFs by asset class, performance, yield and more, check out the
This user currently has no profile.
Retired post 60ish, getting into the market after a long hiatus. would like to become a serious investor, I see a lot of important work out there that needs to be done, bio techs for example, and lots of potential to be gained in the process.
Bonds, Developed International Markets, Mutual funds, Options, REITs, Retirement savings, Stocks - long, Tech stocks
Currently, there is no company profile for romroc.
Currently, there are no blog details for romroc.
Currently, there are no book details for romroc.
Correction: a vial of Actha...
At $28K a vial, Questcor's (QCOR) Acthar has pr...
Most thorough reporting. Th...
Questcor III: After The Earnings
sigh of relief!
Questcor (QCOR): Q3 EPS of $0.91 beats by $0.14...
Couple of points. First, th...
A.P. Pharma: Refiling Of NDA For APF530 Could C...
Xignite quote data
© 2014 Seeking Alpha